BPG is committed to discovery and dissemination of knowledge
Featured Articles
12/27/2020 5:56:55 AM | Browse: 238 | Download: 390
Publication Name World Journal of Stem Cells
Manuscript ID 57915
Country/Territory South Korea
Received
2020-06-30 03:22
Peer-Review Started
2020-06-30 03:23
To Make the First Decision
Return for Revision
2020-10-21 20:23
Revised
2020-10-23 01:28
Second Decision
2020-11-11 09:38
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-11-12 16:59
Articles in Press
2020-11-12 16:59
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2020-12-24 08:42
Publish the Manuscript Online
2020-12-27 05:30
ISSN 1948-0210 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cell Biology
Manuscript Type Review
Article Title Prospects for the therapeutic development of umbilical cord blood-derived mesenchymal stem cells
Manuscript Source Invited Manuscript
All Author List Soyoun Um, Jueun Ha, Soo Jin Choi, Wonil Oh and Hye Jin Jin
Funding Agency and Grant Number
Corresponding Author Hye Jin Jin, PhD, Director, Senior Researcher, Biomedical Research Institute, MEDIPOST Co., Ltd., 21, Daewangpangyo-ro 644-gil, Bundang-gu, Seongnam 13494, South Korea. genny77@medi-post.co.kr
Key Words Umbilical cord blood; Mesenchymal stem cell; Stem cell therapy; Immunomodulation; Regenerative medicine; Therapeutic cell manufacturing processing
Core Tip Umbilical cord blood (UCB) is a primitive and rich source of mesenchymal stem cells (MSCs). UCB-derived MSCs have the potential of exerting profound immunomodulatory effects with the secretion of factors and cytokines. However, the safety and yield of UCB-derived MSCs are still a concern. Next-generation stem cell therapy is necessary, referring to the mass production of efficient stem cells based on the fundamental technology, to improve whole cell processing.
Publish Date 2020-12-27 05:30
Citation Um S, Ha J, Choi SJ, Oh W, Jin HJ. Prospects for the therapeutic development of umbilical cord blood-derived mesenchymal stem cells. World J Stem Cells 2020; 12(12): 1511-1528
URL https://www.wjgnet.com/1948-0210/full/v12/i12/1511.htm
DOI https://dx.doi.org/10.4252/wjsc.v12.i12.1511
Full Article (PDF) WJSC-12-1511.pdf
Full Article (Word) WJSC-12-1511.docx
Manuscript File 57915_Auto_Edited.docx
Answering Reviewers 57915-Answering reviewers.pdf
Audio Core Tip 57915-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 57915-Conflict-of-interest statement.pdf
Copyright License Agreement 57915-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 57915-Language certificate.pdf
Peer-review Report 57915-Peer-review(s).pdf
Scientific Misconduct Check 57915-Bing-Ma YJ-1.jpg
Scientific Misconduct Check 57915-Bing-Liu M-2.PNG
Scientific Misconduct Check 57915-Scientific misconduct check.pdf
Scientific Editor Work List 57915-Scientific editor work list.pdf